Status | Study |
Completed |
Study Name: Mexiletine and Non Dystrophic Myotonias Condition: Non-dystrophic Myotonias Paramyotonia Congenita Date: 2015-01-08 Interventions: Drug: Mexiletine |
Recruiting |
Study Name: Study of Ranolazine in Myotonia Congenita, Paramyotonia Congenita and Myotonic Dystrophy Type 1 Condition: Myotonia Congenita (Enrollment Complete) Paramyotonia Congenita Date: 2014-09-25 Interventions: Drug: Ranolazine Ranexa is FDA approved for chronic angina |
Completed |
Study Name: Combined N-of-1 Trials Mexiletine vs Placebo in Patients With Non-Dystrophic Myotonia (NDM) Condition: Non Dystrophic Myotonia Date: 2013-11-18 Interventions: Drug: Mexiletine |
Completed |
Study Name: Lamotrigine as Treatment of Myotonia Condition: Dystrophia Myotonica Type 1 Myotonia Congenita Date: 2013-08-23 Interventions: Drug: Lamotrigine Other Name: |
Completed |
Study Name: Characteristics of Nondystrophic Myotonias Condition: Nondystrophic Myotonias Myotonia Congenita Myotonic Disord Date: 2005-10-24 |
Completed |
Study Name: Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dichlorphenamide for Periodic Paralyses and Associated Sodium Channel Disorders Condition: Paralysis, Hyperkalemic Periodic Hypokalemic Periodic Paralysis Date: 2000-02-24 Interventions: Drug: dichlorphenamide |